These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21634421)

  • 1. Cyclic nucleotide-gated channel block by hydrolysis-resistant tetracaine derivatives.
    Andrade AL; Melich K; Whatley GG; Kirk SR; Karpen JW
    J Med Chem; 2011 Jul; 54(13):4904-12. PubMed ID: 21634421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modifications to the tetracaine scaffold produce cyclic nucleotide-gated channel blockers with widely varying efficacies.
    Strassmaier T; Uma R; Ghatpande AS; Bandyopadhyay T; Schaffer M; Witte J; McDougal PG; Brown RL; Karpen JW
    J Med Chem; 2005 Sep; 48(18):5805-12. PubMed ID: 16134947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multiply charged tetracaine derivative blocks cyclic nucleotide-gated channels at subnanomolar concentrations.
    Ghatpande AS; Uma R; Karpen JW
    Biochemistry; 2003 Jan; 42(2):265-70. PubMed ID: 12525153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of tetracaine block of cyclic nucleotide-gated channels.
    Fodor AA; Gordon SE; Zagotta WN
    J Gen Physiol; 1997 Jan; 109(1):3-14. PubMed ID: 8997661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Halogen substituents on the aromatic moiety of the tetracaine scaffold improve potency of cyclic nucleotide-gated channel block.
    Kirk SR; Andrade AL; Melich K; Jackson EP; Cuellar E; Karpen JW
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6417-9. PubMed ID: 21944857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetracaine reports a conformational change in the pore of cyclic nucleotide-gated channels.
    Fodor AA; Black KD; Zagotta WN
    J Gen Physiol; 1997 Nov; 110(5):591-600. PubMed ID: 9348330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase-9 and -2 enhance the ligand sensitivity of photoreceptor cyclic nucleotide-gated channels.
    Meighan PC; Meighan SE; Rich ED; Brown RL; Varnum MD
    Channels (Austin); 2012; 6(3):181-96. PubMed ID: 22699690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irreversible activation of cyclic nucleotide-gated ion channels by sulfhydryl-reactive derivatives of cyclic GMP.
    Brown RL; Haley TL; Snow SD
    Biochemistry; 2000 Jan; 39(2):432-41. PubMed ID: 10631005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Block of cyclic nucleotide-gated channels by tetracaine derivatives: role of apolar interactions at two distinct locations.
    Strassmaier T; Kirk SR; Banerji T; Karpen JW
    Bioorg Med Chem Lett; 2008 Jan; 18(2):645-9. PubMed ID: 18055205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity-dependent modulation of rod photoreceptor cyclic nucleotide-gated channels mediated by phosphorylation of a specific tyrosine residue.
    Molokanova E; Maddox F; Luetje CW; Kramer RH
    J Neurosci; 1999 Jun; 19(12):4786-95. PubMed ID: 10366613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All-trans-retinal is a closed-state inhibitor of rod cyclic nucleotide-gated ion channels.
    McCabe SL; Pelosi DM; Tetreault M; Miri A; Nguitragool W; Kovithvathanaphong P; Mahajan R; Zimmerman AL
    J Gen Physiol; 2004 May; 123(5):521-31. PubMed ID: 15078915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics of Ca2+-calmodulin-dependent inhibition of rod cyclic nucleotide-gated channels measured by patch-clamp fluorometry.
    Trudeau MC; Zagotta WN
    J Gen Physiol; 2004 Sep; 124(3):211-23. PubMed ID: 15314069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interdomain interactions underlying activation of cyclic nucleotide-gated channels.
    Varnum MD; Zagotta WN
    Science; 1997 Oct; 278(5335):110-3. PubMed ID: 9311913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine phosphorylation of rod cyclic nucleotide-gated channels switches off Ca2+/calmodulin inhibition.
    Krajewski JL; Luetje CW; Kramer RH
    J Neurosci; 2003 Nov; 23(31):10100-6. PubMed ID: 14602825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoids restore normal cyclic nucleotide sensitivity of mutant ion channels associated with cone dystrophy.
    Tetreault ML; Horrigan DM; Kim JA; Zimmerman AL
    Mol Vis; 2006 Dec; 12():1699-705. PubMed ID: 17213799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of allosteric modulation of rod cyclic nucleotide-gated channels.
    Sunderman ER; Zagotta WN
    J Gen Physiol; 1999 May; 113(5):601-20. PubMed ID: 10228178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered ligand specificity by protonation in the ligand binding domain of cyclic nucleotide-gated channels.
    Gordon SE; Oakley JC; Varnum MD; Zagotta WN
    Biochemistry; 1996 Apr; 35(13):3994-4001. PubMed ID: 8672432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudechetoxin: a peptide blocker of cyclic nucleotide-gated ion channels.
    Brown RL; Haley TL; West KA; Crabb JW
    Proc Natl Acad Sci U S A; 1999 Jan; 96(2):754-9. PubMed ID: 9892706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of modulation by internal protons of cyclic nucleotide-gated channels cloned from sensory receptor cells.
    Gavazzo P; Picco C; Menini A
    Proc Biol Sci; 1997 Aug; 264(1385):1157-65. PubMed ID: 9308192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Movement of gating machinery during the activation of rod cyclic nucleotide-gated channels.
    Brown RL; Snow SD; Haley TL
    Biophys J; 1998 Aug; 75(2):825-33. PubMed ID: 9675183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.